Breast cancer activism: Past lessons, future directions

Nature Reviews Cancer

Volumn 2, Issue 3, 2002, Pages 225-230

  Lerner, Barron H ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RALOXIFENE; TAMOXIFEN; TRASTUZUMAB;

ACTIVISM; BREAST CANCER; CANCER RESEARCH; FEMALE; FINANCIAL MANAGEMENT; FUTUROLOGY; GOVERNMENT; HEALTH CARE ORGANIZATION; HUMAN; PRIORITY JOURNAL; PUBLIC OPINION; REVIEW; SIDE EFFECT; SURVIVAL; UNITED STATES; ARTICLE; BREAST TUMOR; ECONOMICS; HISTORY; MASS MEDIUM; NON PROFIT ORGANIZATION; POLITICS;

AMERICAN CANCER SOCIETY; BREAST NEOPLASMS; FEMALE; HISTORY, 20TH CENTURY; HUMANS; LOBBYING; MASS MEDIA; NATIONAL INSTITUTES OF HEALTH (U.S.); RESEARCH SUPPORT; UNITED STATES;

EID: 0036513571     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc744     Document Type: Review

References (48)

1. Lerner, B. H. The Breast Cancer Wars: Hope, Fear and the Pursuit of a Cure in Twentieth-Century America (Oxford Univ. Press., New York. 2001).
2. Lasser, T. Reach to Recovery (Simon & Schuster, New York, 1972).
3. Seaman, B. The Doctors' Case against the Pill (Peter H. Wyden, New York, 1969).
4. Boston Women's Health Book Collective. Our Bodies, Ourselves: a Book for and by Women (Simon and Schuster, New York, 1973).
5. Klemesrud, J. New voice in debate on breast surgery. New York Times 56 (12 December, 1972).
6. Kushner, R. Breast Cancer: a Personal and an Investigative Report (Harcourt Brace Jovanovich, New York, 1975).
7. Fisher, B. The revolution in breast cancer surgery: science of anecdotalism? World J. Surg. 9, 655-666 (1985).
8. Casamayou, M. H. The Politics of Breast Cancer (Georgetown Univ. Press, Washington DC., 2001).
9. Lerner, B. H. No shrinking violet: Rose Kushner and the rise of American breast cancer activism. West. J. Med. 174, 362-365 (2001).
10. Reagan, L. J. Engendering the dread disease: women, men and cancer. Am. J. Public Health 87, 1779-1787 (1997).
11. Belkin, L. How breast cancer became this year's hot charity. New York Times Magazine 40-57 (22 December, 1996).
12. Waller, M. & Batt, S. Advocacy groups for breast cancer patients Can. Med. Assoc. J. 152, 829-833 (1995).
13. Steimle, S. Europa Donna unites Europe against breast cancer. J. Natl Cancer Inst. 88, 1614-1615 (1996).
14. Hedenfalk, I. et al. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344, 539-548 (2001).
15. Bazell, R. Her-2: the Making of Herceptin, a Revolutionary Treatment for Breast Cancer (Random House, New York, 1998).
16. Fernandez, M. E. et al. Evaluation of ENCORE plus: a community-based breast and cervical cancer screening program. Am. J. Prev. Med. 18, 35-49 (1999).
17. Ruzek, S. B. & Becker, J. The women's health movement in the United States: from grass-roots activism to professional agendas. J. Am. Med. Womens Assoc. 54, 4-8, 40 (1999).
18. Institute of Medicine. Scientific Opportunities and Public Needs: Improving Priority Settings and Public Input at the National Institutes of Health (National Academy Press, Washington DC., 1998).
19. Greenlee, R. T. Hill-Harmon, M. B., Taylor, M. & Thun, M. Cancer statistics. 2001. CA Cancer J. Clin. 51, 15-36 (2001).
20. Ready, T. Little sympathy for ex-smokers. Los Angeles Times S1 (26 March, 2001).
21. Hurst, L. With little attention lung cancer just keeps on killing. Toronto Star A1 (16 June, 2001).
22. Kalb, C., Wingert, P. & Foote, D. Stars, money and medical crusades. Newsweek 58 (22 May, 2000).
23. Olsen, O. & Gøtsche, P. C. Cochrane review on screening for breast cancer with mammography. Lancet 358, 1340-1342 (2001).
24. Kolata, G. Study sets off debate over mammograms' value. New York Times A1 (9 December, 2001).
25. Welch, G. H. Questions about the value of early intervention. N. Engl. J. Med. 334, 1472-1473 (1996).
26. Howe, H. L. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J. Natl Cancer Inst. 93, 824-842 (2001).
27. Canadian Cancer Statistics. (National Cancer Institutes of Canada, Toronto, 2001).
28. Nelson, N. J. Research seeks links between cancer, gene-environment interactions. J. Natl Cancer Inst. 92, 1121-1123 (2000).
29. Fagin, D. Clinton holds cancer hearing: L. I. activists skeptical of progress. New York Newsday A7 (12 June, 2001).
30. Brenner, B. A. A new focus for cancer stamps. Boston Globe A23 (21 July, 2000).
31. Leopoid, E. A Darker Ribbon: Breast Cancer, Women, and Their Doctors in the Twentieth Century (Beacon Press, Boston, 1999).
32. Epstein, S. S. The Politics of Cancer Revisited (East Ridge Press, New York, 1998).
33. Kasper, A. S. & Ferguson, S. J. in Breast Cancer. Society Shapes an Epidemic (eds Kasper A. S. & Ferguson, S. J.) 355-373 (St Martin's Press, New York, 2000).
34. Steingraber, S. Mechanisms, proof, and unmet needs: the perspective of a cancer activist. Environ. Health Perspect. 105, 685-687 (1997).
35. Cornacchia, C. Toxin avengers: not satisfied with waiting for research to find a breast-cancer cure, many who suspect the tainted environment are pushing for action. Montreal Gazette E1 (25 October, 1999).
36. Stellman, S. D. et al. Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol. Biomarkers Prev. 9, 1241-1249 (2000).
37. Wolff, M. S. et al. Risk of breast cancer and organochloride exposure. Cancer Epidemiol. Biomarkers Prev. 9, 271-277 (2000).
38. Key, T. J. et al. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br. J. Cancer 81, 1248-1256 (1999).
39. Fisher, B. et al. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J. Natl Cancer Inst. 90, 1371-1388 (1999).
40. Norsigian, J. et al. Re: weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J. Natl Cancer Inst. 92, 757-758 (2000).
41. Berman, L. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Lancet 356, 881-887 (2000).
42. Powles, T. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 352, 98-101 (1998).
43. Brenner, B. STARs in their eyes. Newsletter of Breast Cancer Action Vol. 55 (August-September, 1999).
44. Rubin, R. Tamoxifen marker ordered to back off breast cancer claims. USA Today 10D (8 August, 2000).
45. Zones, J. S. Strangers in our own land. Newsletter of Breast Cancer Action 67, 5 (September-October, 2001).
46. Cornacchia, C. Victims of our own success, breast-cancer activist says. Montreal Gazette A12 (29 July, 1999).
47. Leopold, E. Shopping for the cure. The Prospect (24 September-2 October, 2000).
48. Zones, J. S. in Breast Cancer: Society Shapes an Epidemic (eds Kasper, A. S. & Ferguson, S. J.) 119-151 (St Martin's Press, New York, 2000).